Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care

被引：0

作者：

Tack, J. ^{[1
]}

Louis, E. ^{[2
,3
]}

Persy, V. ^{[4
]}

Urbain, D. ^{[5
]}

机构：

[1] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, B-3000 Louvain, Belgium

[2] CHU, Liege, Belgium

[3] Univ Liege, Liege, Belgium

[4] Hugin Mugin Res, Antwerp, Belgium

[5] Vrije Univ Brussel, UZ Brussel, Dept Gastroenterol, Brussels, Belgium

来源：

ACTA GASTRO-ENTEROLOGICA BELGICA | 2013年 / 76卷 / 04期

关键词：

Proton pump inhibitors; acid peptic diseases; best practices; review; GASTROESOPHAGEAL-REFLUX DISEASE; FUNCTIONAL DYSPEPSIA; HELICOBACTER-PYLORI; CLINICAL-TRIALS; ESOPHAGEAL PH; PPI THERAPY; LIFE-STYLE; SYMPTOMATIC PATIENTS; GENERAL-POPULATION; DOUBLE-BLIND;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Heartburn, reflux and epigastric pain are frequently encountered symptoms in primary care medicine. Acid peptic diseases such as peptic ulcer and gastrointestinal reflux disease have a high prevalence, can have important impact on patient quality of life and represent a considerable health care cost. Proton pump inhibitors (PPIs) are the most potent pharmacological inhibitors of gastric acid secretion currently available and are the mainstay medical therapy for acid peptic diseases. This review summarizes current evidence on treatment of acid-peptic diseases with proton pump inhibitors and provides primary care clinicians with best practice guidelines for optimal use of these drugs.

引用

页码：393 / 402

页数：10

共 50 条

[1] Reversible pheripheral edema in female patients taking proton pump inhibitors for peptic acid diseases
Brunner, G
Athmann, C
Boldt, JH
DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (05) : 993 - 996
[2] Reversible Pheripheral Edema in Female Patients Taking Proton Pump Inhibitors for Peptic Acid Diseases
G. Brunner
C. Athmann
J.H. Boldt
Digestive Diseases and Sciences, 2001, 46 : 993 - 996
[3] Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases
Robinson, M
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (06) : 709 - 715
[4] Appropriate Use of Intravenous Proton Pump Inhibitors in the Management of Bleeding Peptic Ulcer
Venodhar R. Julapalli
David Y. Graham
Digestive Diseases and Sciences, 2005, 50 : 1185 - 1193
[5] Appropriate use of intravenous proton pump inhibitors in the management of bleeding peptic ulcer
Julapalli, VR
Graham, DY
DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (07) : 1185 - 1193
[6] A safety review of proton pump inhibitors to treat acid-related digestive diseases
Savarino, Edoardo
Marabotto, Elisa
Zentilin, Patrizia
Furnari, Manuele
Bodini, Giorgia
Pellegatta, Gaia
Lorenzon, Greta
Della Coletta, Marco
Ghisa, Matteo
Coppo, Claudia
Marinelli, Carla
Savarino, Vincenzo
EXPERT OPINION ON DRUG SAFETY, 2018, 17 (08) : 785 - 794
[7] The appropriate use of proton-pump inhibitors
Savarino, Vincenzo
Marabotto, Elisa
Zentilin, Patrizia
Furnari, Manuele
Bodini, Giorgia
De Maria, Costanza
Pellegatta, Gaia
Coppo, Claudia
Savarino, Edoardo
MINERVA MEDICA, 2018, 109 (05) : 386 - 399
[8] Evaluation of use of proton pump inhibitors in Greece
Ntaios, George
Chatzinikolaou, Anastasia
Kaiafa, Georgia
Savopoulos, Christos
Hatzitolios, Apostolos
Karamitsos, Dimitrios
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2009, 20 (02) : 171 - 173
[9] A Study on the Efficacy of Proton Pump Inhibitors in Helicobacter pylon-Negative Primary Care Patients with Dyspepsia in Japan
Kamada, Tomoari
Fujimura, Yoshinori
Gotoh, Kensuke
Imamura, Hiroshi
Manabe, Noriaki
Kusunoki, Hiroaki
Inoue, Kazuhiko
Shiotani, Akiko
Hata, Jiro
Haruma, Ken
GUT AND LIVER, 2013, 7 (01) : 16 - 22
[10] Proton Pump Inhibitors: Rational Use and Use-Reduction - The Windsor Workshop
Kahrilas, Peter
Anastasiou, Foteini
Bredenoord, Albert J.
El Serag, Hashem B.
Labenz, Joachim
Mendive, Juan
Savarino, Edoardo V.
Sifrim, Daniel
Udrescu, Mihaela
Yadlapati, Rena
Hungin, A. Pali
DIGESTIVE DISEASES, 2024, 42 (03) : 211 - 220

← 1 2 3 4 5 →